2026-10-15T09:24:38Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34513729 2026-10-14T17:31:17Z category_7 category_12 category_734 category_106 portal_5 item_type_3 month_year_10_2026

<p>Dataset underlying the analyses reported in the manuscript.</p> Paolo Rocco (17224294) Valentina Pagella (25823464) Umberto M. Musazzi (25823467) Sara Manellari (25823470) Elena Paola Lanati (25823473) Paola Minghetti (3946373) Medicine Cell Biology Biological Sciences not elsewhere classified Science Policy primary therapeutic target heterogenous geographical distribution nervous system disorders mobile applications represent based medical devices 65 %), followed 254 eligible trials div >< p clinical trials registrations fund dtx research dtx clinical development clinical use psychiatric disorders italy represent based tools 32 %), development emerge dtx development virtual reality updated overview tr 11147 reimbursement policies regulatory priorities regulatory fragmentation primarily conducted prevalent technology paper provides north america namely psychiatric mostly indicated key factors january 2025 informing policy healthcare systems gov reveals gov </ fragmented policies expanding rapidly ethical issues digital therapeutics different capacity deliver evidence defined according comprehensive overviews clear direction cdigital therapeutics active countries 41 %) 20 %). <p>- Excel dataset containing the 254 clinical trials included in the study and the variables used for classification and analysis.</p> <p>(XLSX)</p> 2026-10-14T17:31:14Z Dataset Dataset 10.1371/journal.pdig.0001750.s002 https://figshare.com/articles/dataset/_p_Dataset_underlying_the_analyses_reported_in_the_manuscript_p_/34513729 CC BY 4.0